CD24 and neoplasm: To verify this hypothesis, we analyzed chromosomal aberrations, transcriptome changes, and the presence of CD44+CD24- CSCs in different morphological structures: tubular, solid, alveolar, and trabecular structures, as well as discrete groups of tumor cells.